Roche, Herzog&De MeuronM&ARoche makes takeover bid for Poseida Therapeutics IncLatest NewsGenentech, the US arm of Swiss-based Roche AG, plans to acquire its long-time partner in allogeneic CAR-T blood cancer and gene therapies, Poseida Therapeutics Inc, for up to US$1.5bn. Read more 26 November 2024 https://european-biotechnology.com/wp-content/uploads/2024/06/Roche3.png 910 1608 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-11-26 20:50:152024-11-27 08:28:26Roche makes takeover bid for Poseida Therapeutics Inc